MedicCoin Unveils International Adoption Strategy Based on Integrating Blockchain Technology into Everyday Life
Strategy focuses on improving health of mankind through blockchain-powered rewards, advancing scientific research and charitable donations
NEW YORK, April 24, 2018 (GLOBE NEWSWIRE) -- via NetworkWire -- MedicCoin, a community-driven crypto focused on improving the lives of millions worldwide, today provides the multifaceted roadmap established for global adoption while recapping practical innovations that set MedicCoin apart for everyday use.
Introducing Multiple Ways to Earn Crypto as a Reward for Positive Choices
The MedicCoin founders envisioned using blockchain technology to make life better for all mankind. A key part of staying true to this vision is ensuring people around the world can join the MedicCoin community without highly technical skills or expensive mining equipment.
Living an Active Lifestyle
By simply installing the MedicWalk app and staying active, anyone will be able to acquire MedicCoin. MedicWalk will be launched within the next few weeks.
Donating Unused Computer Power to Stanford University's Disease Research Program
MedicCoin offers the opportunity to earn coins by donating computer power to Stanford University's Folding@home program, which helps scientists solve computer calculations related to finding cures for Alzheimer's, Parkinson's, Huntington's, many forms of cancer and other types of diseases.
Following Doctor Instructions
Failure to complete medical regimens is a common and costly problem worldwide. Physicians who join and support the network will be provided with MedicCoin for rewarding patients who show up for appointments and follow instructions.
Key Innovations to Accelerate Global Adoption
MedicCoin aims to become the preferred choice for accepting payments among healthcare professionals, all merchant types and individuals by incorporating the latest innovations in crypto and blockchain technology.
MedicEMR: The First Free Opensource EMR Software Accepting Cryptocurrency (MedicCoin)
MedicEMR will be introduced to combine opensource OpenEMR software with crypto payments. In addition to rewarding physicians and patients with MedicCoin for using the software, MedicEMR aims to increase access to high-quality medical care for all people regardless of race, socioeconomic status or geographic location by building awareness of the free, opensource software.
MedicPhone: An Integrated TeleMedicine App Accepting Cryptocurrency (MedicCoin)
MedicPhone is being designed for people who face immobility challenges or logistical complications. In addition to giving access to board-certified doctors 24 hours a day, seven days a week, MedicPhone will integrate MedicEMR and accept MedicCoin alongside other payment methods.
Private and Lightning-Fast Transactions for All Merchant Types
Integrated privacy technology ensures users can maintain a confidential transaction history with different healthcare providers, individuals, merchants and other establishments. InstantX enables users to avoid the long delays common with most cryptocurrencies, like bitcoin, so MedicCoin is viable wherever conventional payment methods are used.
To increase visibility of prior accomplishments and future announcements, key members of the MedicCoin community chose to engage multiple communication channels and platforms to ensure ongoing media coverage via syndicated articles and editorials, journalist outreach, a MedicCoin-branded news portal, and various engagement initiatives.
MedicCoin (MEDIC) is a blockchain-based crypto focused on promoting health and philanthropy throughout the world by rewarding individuals in various ways for being healthy as well as donating their unused computer power to Stanford University's Folding@home project. Initiatives currently underway will introduce MedicEMR, a free open-source EMR software integrating MedicCoin; MedicPhone, a telemedicine app that allows patients to see doctors remotely, integrates MedicEMR and provides MedicCoin as a payment option; and MedicWalk, a smartphone app that rewards individuals for staying active.
To learn more, visit: https://mediccoin.com/
Engage with the MedicCoin Community
Discord chat via https://discordapp.com/invite/SjudnyK
Twitter via https://twitter.com/mediccoin
Facebook via https://www.facebook.com/mediccoin
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: MedicCoin via Globenewswire
Om Nasdaq GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York
+1 212 401 8700http://www.nasdaqomx.com
NASDAQ (NASDAQ: NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents.
Følg saker fra Nasdaq GlobeNewswire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Nasdaq GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Nasdaq GlobeNewswire
Atico Reports Consolidated Financial Results for the First Quarter of 201824.5.2018 22:30 | Pressemelding
(All amounts expressed in US dollars, unless otherwise stated) VANCOUVER, British Columbia, May 24, 2018 (GLOBE NEWSWIRE) -- Atico Mining Corporation (the "Company" or "Atico") (TSX.V:ATY) (OTC:ATCMF) today announced its financial results for the three months ended March 31, 2018, posting a net income of $0.4 million. Fernando E. Ganoza, CEO and Director, commented, "The strong production and all-in sustaining cash cost of $1.85 achieved this quarter is not reflected in the financial results as a large concentrate shipment was delayed to the second quarter, along with the revenue associated with those tonnes. The shipping schedule is expected to stabilize during the second quarter, where we will then benefit from the additional shipped concentrate and recognized revenue. We anticipate strong financial results in the next quarter." Mr. Ganoza continued, "Our emphasis will continue to be on further strengthening our balance sheet, improving production costs and most importantly regional
Luxembourg Announced as SNOMED International's Newest Member24.5.2018 15:16 | Pressemelding
London, United Kingdom, May 24, 2018 (GLOBE NEWSWIRE) -- SNOMED International and Agence eSanté Luxembourg are pleased to announce that Luxembourg has joined the organization as its thirty-second Member. Luxembourg, one of the leading nations in the area of information and communication technology, has set the development of eHealth technologies as a high priority. Agence eSanté, Luxembourg's national agency for the exchange and sharing of medical data, has set an overall mission to facilitate clinical information exchange both within Luxembourg and across other international actors. To work towards this reality, the agency has taken part in discussions about standardization across Europe, a contributing building block achieved with its membership in SNOMED International. With their membership, Agence eSanté has committed their support for the use of structured clinical terminology. When applied to the health sector, interoperability ensures that information systems, and through them h
SEMAFO Signs Underground Mining Services Contract with AUMS24.5.2018 14:00 | Pressemelding
MONTREAL, May 24, 2018 (GLOBE NEWSWIRE) -- SEMAFO Inc. (TSX:SMF) (OMX:SMF) reports that it has signed a mining services contract with African Underground Mining Services ("AUMS") to provide turnkey mining services for Siou underground. AUMS is a well-known and reputable mining contractor with underground experience in Burkina Faso and across Africa. Under the mining services contract, AUMS will be responsible for supplying the mining fleet and a skilled labour force for Siou underground in addition to ensuring development, production and auxiliary services. SEMAFO will provide technical services including geology and engineering as well as leveraging the existing surface infrastructure at Mana. The mining services contract has a term of 70 months. The economic terms of the mining services contract are consistent with the economics presented in the Mana pre-feasibility study filed March 29, 2018 on SEDAR. Preparatory work has already commenced on Siou underground with full project deplo
Merus Announces First Patient Dosed in Phase 1 Clinical Trial of MCLA-158 in Patients with Solid Tumors24.5.2018 13:00 | Pressemelding
- IND Accepted in April by the U.S. FDA for MCLA-158 - UTRECHT, The Netherlands, May 24, 2018 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq:MRUS), a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics (Biclonics®), today announced that the first patient has been dosed in a Phase 1, first-in human clinical trial of MCLA-158 in patients with solid tumors with an initial focus on metastatic colorectal cancer. The trial will be conducted in Europe, where several Clinical Trial Applications (CTAs) have been approved to date. The Company also announced the submission of an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for MCLA-158, which was accepted by the FDA in April 2018. With this acceptance, Merus plans to open additional sites for this trial in the United States. MCLA-158 is designed to bind to cancer stem cells expressing leucine-rich repeat-containing G protein-coupled receptor 5 (Lgr5) and epidermal grow
PRA Named International Clinical Research Company of the Year24.5.2018 10:00 | Pressemelding
RALEIGH, N.C., May 24, 2018 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ:PRAH) is pleased to announce it was recognized by PharmaTimes as the International Clinical Research Company of the Year. This is the fifth year in a row that PRA has received this award. "This award celebrates excellence in the clinical research industry and we are honored to once again be recognized by our peers," said Colin Shannon, President and Chief Executive Officer. "This award is possible thanks to the incredibly talented PRA team members we have working around the world who are deeply committed to their work in bringing new and life-saving therapies to the patients who need them." PRA also swept the Clinical Research Associate and Clinical Trial Administrator categories capturing a total of 11 awards. These awards follow PRA's recognition earlier this month in the PharmaTimes Americas competition where PRA also received 11 awards, including Company of the Year. The PharmaTimes, International Cli
Early Warning Report23.5.2018 20:05 | Pressemelding
VANCOUVER, British Columbia, May 23, 2018 (GLOBE NEWSWIRE) -- Fortuna Silver Mines Inc. (NYSE:FSM) (TSX:FVI) announces that pursuant to a warrant exercise, it has acquired for a purchase price of C$803,571, direct ownership of 5,357,142 common shares (the "Shares") of Prospero Silver Corp. ("Prospero"), of 510 West Georgia Street, Suite 1800, Vancouver, BC V6B 0M3, at a price of C$0.15 per Share. Immediately following this transaction, Fortuna owned 10,714,284 common shares of Prospero, representing 22.74% of the issued and outstanding common shares of Prospero. Immediately prior to the transaction, Fortuna owned 5,357,142 common shares and 5,357,142 common share purchase warrants. The Shares were acquired by Fortuna for investment purposes, and depending on market and other conditions, it may from time to time in the future increase or decrease its ownership, control or direction over securities of Prospero through market transactions, private agreements, or otherwise. Fortuna has fil
I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.Besøk vårt presserom